Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3862882rdf:typepubmed:Citationlld:pubmed
pubmed-article:3862882lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:3862882lifeskim:mentionsumls-concept:C0000726lld:lifeskim
pubmed-article:3862882lifeskim:mentionsumls-concept:C0015388lld:lifeskim
pubmed-article:3862882lifeskim:mentionsumls-concept:C0230139lld:lifeskim
pubmed-article:3862882lifeskim:mentionsumls-concept:C0086045lld:lifeskim
pubmed-article:3862882lifeskim:mentionsumls-concept:C0227435lld:lifeskim
pubmed-article:3862882lifeskim:mentionsumls-concept:C0007549lld:lifeskim
pubmed-article:3862882lifeskim:mentionsumls-concept:C1621368lld:lifeskim
pubmed-article:3862882pubmed:issue6lld:pubmed
pubmed-article:3862882pubmed:dateCreated1985-11-8lld:pubmed
pubmed-article:3862882pubmed:abstractTextWe investigated the concentrations of cefmenoxime (CMX) after administration of 2 g of CMX, in the tissues resected during operation 2 hours after the beginning of intravenous drip infusion, and in the exudates from abdominal or thoracic cavities in the postoperative period. The results were as follows: The highest tissue concentration of CMX was found in the liver (59.0 +/- 20.3 micrograms/g), and the lowest was in the pancreas (13.9 +/- 8.1 micrograms/g). The concentrations of CMX in the tissues were in order of liver much greater than colon = esophagus = stomach greater than pancreas. The peak concentration of CMX in exudate from thoracic cavity was 15.6 +/- 10.1 micrograms/ml, and was observed 2 hours after the beginning of intravenous drip infusion, later than that in serum. Furthermore, the concentration of the exudate was maintained to a reasonable extent for 5 hours. The concentrations of CMX in both tissues and exudates were enough to inhibit the growth of many kinds of bacteria isolated from abdominal infections.lld:pubmed
pubmed-article:3862882pubmed:languagejpnlld:pubmed
pubmed-article:3862882pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3862882pubmed:citationSubsetIMlld:pubmed
pubmed-article:3862882pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3862882pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3862882pubmed:statusMEDLINElld:pubmed
pubmed-article:3862882pubmed:monthJunlld:pubmed
pubmed-article:3862882pubmed:issn0368-2781lld:pubmed
pubmed-article:3862882pubmed:authorpubmed-author:KatagiriSSlld:pubmed
pubmed-article:3862882pubmed:authorpubmed-author:HaraTTlld:pubmed
pubmed-article:3862882pubmed:authorpubmed-author:TakahashiCClld:pubmed
pubmed-article:3862882pubmed:authorpubmed-author:YagiSSlld:pubmed
pubmed-article:3862882pubmed:authorpubmed-author:KameyamaJJlld:pubmed
pubmed-article:3862882pubmed:authorpubmed-author:IshiyamaSSlld:pubmed
pubmed-article:3862882pubmed:authorpubmed-author:TsukamotoMMlld:pubmed
pubmed-article:3862882pubmed:authorpubmed-author:SeoNNlld:pubmed
pubmed-article:3862882pubmed:authorpubmed-author:HoshikawaTTlld:pubmed
pubmed-article:3862882pubmed:authorpubmed-author:IizawaHHlld:pubmed
pubmed-article:3862882pubmed:issnTypePrintlld:pubmed
pubmed-article:3862882pubmed:volume38lld:pubmed
pubmed-article:3862882pubmed:ownerNLMlld:pubmed
pubmed-article:3862882pubmed:authorsCompleteYlld:pubmed
pubmed-article:3862882pubmed:pagination1643-7lld:pubmed
pubmed-article:3862882pubmed:dateRevised2009-11-11lld:pubmed
pubmed-article:3862882pubmed:meshHeadingpubmed-meshheading:3862882-...lld:pubmed
pubmed-article:3862882pubmed:meshHeadingpubmed-meshheading:3862882-...lld:pubmed
pubmed-article:3862882pubmed:meshHeadingpubmed-meshheading:3862882-...lld:pubmed
pubmed-article:3862882pubmed:meshHeadingpubmed-meshheading:3862882-...lld:pubmed
pubmed-article:3862882pubmed:meshHeadingpubmed-meshheading:3862882-...lld:pubmed
pubmed-article:3862882pubmed:meshHeadingpubmed-meshheading:3862882-...lld:pubmed
pubmed-article:3862882pubmed:meshHeadingpubmed-meshheading:3862882-...lld:pubmed
pubmed-article:3862882pubmed:meshHeadingpubmed-meshheading:3862882-...lld:pubmed
pubmed-article:3862882pubmed:meshHeadingpubmed-meshheading:3862882-...lld:pubmed
pubmed-article:3862882pubmed:meshHeadingpubmed-meshheading:3862882-...lld:pubmed
pubmed-article:3862882pubmed:meshHeadingpubmed-meshheading:3862882-...lld:pubmed
pubmed-article:3862882pubmed:meshHeadingpubmed-meshheading:3862882-...lld:pubmed
pubmed-article:3862882pubmed:year1985lld:pubmed
pubmed-article:3862882pubmed:articleTitle[The concentration of cefmenoxime after intravenous drip infusion in digestive organs and exudates from abdominal and thoracic cavities in human].lld:pubmed
pubmed-article:3862882pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3862882pubmed:publicationTypeEnglish Abstractlld:pubmed